Aronson, J.K. & Reynolds, D. J. M. (1992) Lithium. British Medical Journal, 305, 1273–1276.
Bell, A. J. & Ferrier, I. N. (1995) Lithium – induced neurotoxicity at therapeutic levels – an aetiological review. Lithium, in press.
Birch, N. J., Grof, P., Hullin, R. P.
et al (1993) Lithium prophylaxis: Proposed guidelines for good clinical practice. Lithium, 4, 225–230.
Bochetta, A., Bernardi, F., Burrai, C.
et al (1992) The course of thyroid abnormalities during lithium treatment: a two year follow-up study. Acta Psychiatrica Scandinavica, 86, 38–41.
De Montigny, C., Cournoyer, G., Morissette, R.
et al (1983) Lithium carbonate addition to tricyclic antidepressant-resistant unipolar depression. Archives of General Psychiatry, 40, 1327–1334.
Gelenberg, A. J., Kane, J. M., Keller, M. B.
et al (1989) Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. New England Journal of Medicine, 321, 1489–1493.
Goodwin, G. M. (1994) Recurrence of mania after lithium withdrawal. British Journal of Psychiatry, 164, 149–152.
Grof, P., Zis, A. P., Goodwin, F. E.
et al (1978) Patterns of recurrence in bipolar affective illness. Scientific Proceedings of American Psychiatric Association, 179, 120.
Hopkins, H. S. & Gelenberg, A. J. (1994) Treatment of bipolar disorder, how far have we come?
Psychopharmacology Bulletin, 30, 27–38.
Jefferson, J. W. (1990) Lithium; the present and the future. Journal of Clinical Psychiatry, 51 (suppl), 4–8.
Johnson, F. N. (1987) Depression and mania: modern lithium therapy. Oxford: IRL Press.
Lee, S., Chow, C. C., Wing, Y. K.
et al (1992) Thyroid abnormalities during chronic lithium therapy in Hong Kong Chinese: a controlled study. Journal of Affective Disorders, 26, 173–178.
Myers, D. H., Carter, R. A., Burns, B. H.
et al (1985) A prospective study of the effect of lithium on thyroid function and on the prevalence of antithyroid antibodies. Psychological Medicine, 15, 55–61.
Peet, M. & Pratt, J. P. (1993) Lithium. Current status in psychiatric disorder. Drugs, 46, 7–17.
Perry, P. J., Alexander, B., Prince, R. A.
et al (1986) The utility of a single-point dosing protocol for predicting steady-state lithium levels. British Journal of Psychiatry, 148, 401–405.
Post, R. M. (1993) Issues in the long-term management of bipolar affective illness. Psychiatric Annals, 23, 86–93.
Price, L. H., Charney, D. S. & Henninger, G. R. (1986) Variability of response to lithium augmentation in refractory depression. American Journal of Psychiatry, 143, 1387–1392.
Prien, R. F., Caffey, E. M. & Klett, C. J. (1972) Relationship between serum lithium level and clinical response in acute mania treated with lithium. British Journal of Psychiatry, 120, 189–192.
Schou, M. (1984) Long lasting neurological sequelae after lithium intoxication. Acta Psychiatrica Scandinavica, 70, 594–602.
Schou, M. (1988) Effects of long-term lithium treatment on kidney function; an overview. Journal of Psychiatric Research, 22, 287–296.
Sheean, G. L. (1993) Lithium neurotoxicity. Clinical and Experimental Neurology, 14, 112–127.
Small, J. G. & Millstein, V. (1990) Lithium interactions; lithium and electroconvulsive therapy. Journal of Clinical Psychopharmacology, 10, 346–350.
Tyrer, S. P. (1994) Lithium and treatment of aggressive behaviour. European Neuropsychopharmacology, 4, 234–236.
Tyrer, S. P., Shopsin, B. & Aronson, M. (1983) Dangers of reducing lithium. British Journal of Psychiatry, 142, 427.
Verdoux, H. & Bourgeois, M. L. (1990) A case of lithium neurotoxicity with irreversible cerebellar syndrome. Journal of Nervous and Mental Diseases, 178, 761–762.
Vestergaard, P., Poulstrup, I., Schou, M. (1988) Studies on a lithium cohort, 3; tremor, weight gain, diarrhoea, psychological complaints. Acta Psychiatrica Scandinavica, 78, 434–441.
Wilson, R., McKillop, J. H., Crocket, G. T.
et al (1991) The effect of lithium therapy on parameters thought to be involved in the development of auto-immune thyroid disease. Clinical Endocrinology, 34, 357–361.
Wright, B. A. & Jarrett, D. B. (1991) Lithium and calcium channel blockers: possible neurotoxicity. Biological Psychiatry, 30, 635636.